세계의 포인트 오브 케어(POC) 진단 검사 시장 : 제12판

Now in its twelfth edition - Worldwide Market for Point-of-Care (POC) Diagnostic Tests analyzes the POC market from a global perspective with a five-year forecast.

"Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition" provides a comprehensive analysis of the global POC diagnostics market, with forecasts extending through 2029. While traditional lab-based analyzers remain central to the in vitro diagnostics (IVD) industry, the POC segment has emerged as a dynamic growth area, driven by the demand for rapid, accessible testing across diverse healthcare settings.

This twelfth edition builds on Kalorama Information's two decades of expertise in tracking POC trends, offering detailed insights into the evolving role of diagnostics in enhancing patient care, supporting clinical decision-making, and enabling decentralized testing-from hospitals to homes. The report highlights how technological innovations such as smartphones, biosensors, lab-on-a-chip platforms, and wearable devices are reshaping the POC landscape.

The study features in-depth segmentation across key test categories-including glucose, cardiac markers, infectious diseases, and critical care-and provides market sizing, growth projections, and competitive analysis. It also examines the diverse venues where POC testing is performed, from emergency departments and retail clinics to nursing homes and self-testing environments.

Enhanced Segmentation - Many Reports in One

The report delves into various areas of POC diagnostics, including:

• Blood and Electrolytes (including Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC)
• Cancer Tumor Markers
• Cardiac Markers
• Coagulation
• Colon Cancer
• Drugs of Abuse
• Fecal Occult Blood
• Glucose (including CGM and Diabetes/HbA1c)
• Infectious Disease (including C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others)
• Lipid
• Pregnancy/Fertility
• Urine
• Other Testing (including allergy, autoimmune, microbiology, TSH)

Each area is thoroughly analyzed, providing market sizing and forecasts.

Scope and Methodology

With global coverage spanning the U.S., Europe, Japan, and emerging markets, the report offers regional breakdowns and insights into regulatory trends, such as the pursuit of CLIA waivers and CE Marks. Data is based on extensive primary and secondary research, including interviews with over 35 industry stakeholders. Market estimates reflect manufacturer-level revenues, with forecasts from 2024 to 2029 and compound annual growth rates (CAGRs) for each segment.

WHO BENEFITS – DEFINITE TARGETS

Diagnostic and Medical Device Companies

• Product managers, strategic planners, and business development leaders in companies that manufacture or distribute POC devices.
• Teams looking to identify growth opportunities, track technology trends, and assess market sizing for new or existing product lines.

Investors and Private Equity Firms

• Healthcare investors seeking data-backed insights into high-growth diagnostics segments.
• Firms evaluating acquisition targets or considering entry into the POC diagnostics space.

POTENTIAL PAIN POINTS ADDRESSED

Uncertainty About Where the Market Is Growing

The report offers clear five-year forecasts by test type and region—helping users decide where to invest, launch, or expand.

Lack of Granular Market Data

With enhanced segmentation, the report addresses the need for detailed insights across test categories (e.g., glucose, colon cancer, HIV, etc.), replacing the need to purchase multiple niche reports.

Confusion About Competitive Landscape

Provides competitive analysis, helping companies understand who the key players are and where they are succeeding.

Need to Justify Business Decisions with Market Evidence

Market sizing, growth rates, and data-driven validation enable evidence-based planning for R&D, M&A, and product strategy.

Navigating Technological Shifts in Diagnostics

Identifies disruptive innovations such as smartphones, lab-on-a-chip, and wearable POC tools—guiding future product development and partnerships.

Regulatory Uncertainty

Tracks regulatory trends, helping teams assess approval hurdles and align development with market-access strategy.

Table of Contents

Chapter 1: Executive Summary

• Introduction
• Scope and Methodology
• Size and Growth of the Market
  • Table 1-1: Global POC Test Market, 2024-2029 ($ million)
  • Figure 1-1: Global POC Test Market, 2024-2029 ($ million)
• Trends Affecting the Market
• Competitive Outlook
• Sixteen Key Market Conclusions
  • Conclusion One - POC Market Transformed by Technological Progress
  • Conclusion Two - POC Molecular Diagnostics Continue Making Inroads
  • Conclusion Three - Prevention and Early Detection at the Core of POC Development
  • Conclusion Four - Wearables Continue to Influence POC Markets
  • Conclusion Five - Test Costs Will Remain a Global Challenge
  • Conclusion Six - Rising Demand Will Drive POC Growth in RoW Markets
  • Conclusion Seven - New Venues: Urgent & Retail Care
  • Conclusion Eight - COVID-19's Positive Effect
  • Conclusion Nine - New Opportunities in Infectious Disease POC Testing
  • Conclusion Ten - Supply Chain Delays
  • Conclusion Eleven - Multiplex Testing Expands Rapidly
  • Conclusion Twelve - AI Making Inroads into POC
  • Conclusion Thirteen - Stand-Alone ER/Urgent Care Centers Gain Acceptance
  • Conclusion Fourteen - Digital Diagnostics and POC
  • Conclusion Fifteen - Microfluidics Gaining Ground in POC
  • Conclusion Sixteen - New Technologies Driving POC Growth

Chapter 2: Introduction and Overview

• Point-of-Care Diagnostics Testing
• Industry Regulations
  • Types of CLIA Certificates
• POC Industry Drivers
  • Patient focused drivers
  • Medical/Healthcare related drivers
  • Technology drivers
  • Economic drivers
  • Other drivers
• POC Industry Challenges
• POC Test Types
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath
• Conditions Evaluated by POC Diagnostic Testing
  • Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Cardiovascular Disease
  • Diabetes
  • Drug Abuse
  • Infectious Disease
  • Herpes
  • HTLV
  • Respiratory Syncytial Virus
  • Hepatitis
  • Lyme Disease
  • Babesiosis
  • Gonorrhea, Syphilis and Chlamydia
  • Trichomonas Vaginalis
  • HIV/AIDS
  • Helicobacter Pylori
  • Influenza
  • Coronavirus
  • Mononucleosis
  • Streptococcus
  • Osteoporosis
  • Pregnancy and Fertility

Chapter 3: POC Blood Glucose Tests

• Types of Blood Glucose Testing
  • Fasting Blood Sugar (FBS)
  • 2-Hour Postprandial Blood Sugar (PPBS)
  • Random Blood Sugar
  • Glucose Tolerance Test
  • Glucose Urine Test
  • Glycated Hemoglobin (HbA1c)
• Products
  • Blood Glucose Self-Testing
    • Table 3-1: Selected Glucose Self-Test Meter Innovations
    • Table 3-2: Selected Apps and Glucose Management IT
  • Continuous Self-Testing
  • Glycated Hemoglobin Tests
    • Table 3-3: Selected POC HbA1c Devices
  • Professional
• Market Size and Growth
  • Table 3-4: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2024-2029 ($ million)
  • Figure 3-1: Global POC Glucose (including CGM and HbA1c) Testing Market Analysis, 2024-2029 ($ million)
  • Table 3-5: Global POC Diabetes Sales, by Test Category, 2024-2029 ($ million) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
  • Figure 3-2: Global POC Diabetes Sales, by Test Category, 2024-2029 ($ million) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
  • Figure 3-3: Global POC Diabetes Share, by Test Category, 2024 (%) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
  • Figure 3-4: Global POC Diabetes Share, by Test Category, 2029 (%) [Glucose, Self-test; Glucose, professional; Glucose, continuous; HbA1c, POC]
• Regional Analysis
  • Figure 3-5: POC Blood Glucose Testing Regional Market Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
• POC Glucose Self-Testing
  • Table 3-6: Global POC Glucose Self-Testing Market, 2024-2029 ($ million)
  • Figure 3-6: Global POC Glucose Self-Testing Market, 2024-2029 ($ million)
• POC Continuous Glucose Self-Testing
  • Table 3-7: Global POC Continuous Glucose Self-Testing Market, 2024-2029 ($ million)
  • Figure 3-7: Global POC Continuous Glucose Self-Testing Market, 2024-2029 ($ million)
• POC Glucose Professional Testing
  • Table 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2024-2029 ($ million)
  • Figure 3-8: Global POC Glucose Professional Testing Market (excludes HbA1c testing), 2024-2029 ($ million)
• POC HbA1c Testing
  • Table 3-9: Global POC Glucose HbA1c Professional Testing Market, 2024-2029 ($ million)
  • Figure 3-9: Global POC Glucose HbA1c Professional Testing Market, 2024-2029 ($ million)
• Competitive Analysis
  • Table 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
  • Figure 3-10: Global POC Blood Glucose Testing Market (BGM, CGM, HbA1c) Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]
  • Figure 3-11: Global POC Glucose Test Manufacturer Shares, by Leading Suppliers, 2024 (%) [Abbott, Ascensia, Dexcom, LifeScan, Medtronic, Roche, Others]

Chapter 4: POC Blood and Electrolytes Testing Market

• Types of Blood and Electrolytes Tests
  • Hemoglobin/Hematocrit
  • WBC and Other
  • Blood Gases
  • Electrolytes
  • Products
    • Table 4-1: Selected POC Hemoglobin and Hematocrit Systems, 2024
    • Table 4-2: Selected POC Hematology Analyzer Systems, 2024
  • Market Size and Growth
    • Table 4-3: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC) Market Analysis, 2024-2029 ($ million)
    • Figure 4-1: Global POC Blood and Electrolytes Testing (Blood Gases/Electrolytes, Hemoglobin/Hematocrit, WBC) Market Analysis, 2024-2029 ($ million)
    • Table 4-4: Global POC Blood & Electrolytes Revenues, by Test Category, 2024-2029 ($ million) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
    • Figure 4-2: Global POC Blood & Electrolytes Revenues, by Test Category, 2024-2029 ($ million) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
    • Figure 4-3: Global POC Blood & Electrolytes Market Share, by Test Category, 2024 (%) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
    • Figure 4-4: Global POC Blood & Electrolytes Market Share, by Test Category, 2029 (%) [Blood Gases & Electrolytes (inc. critical care), Hematocrit/ Hemoglobin, WBC other routine]
  • Regional Analysis
    • Figure 4-5: POC Blood and Electrolytes Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Blood and Electrolyte Self-Testing
    • Table 4-5: Global POC Blood and Electrolyte Self Testing Market Analysis, 2024-2029 ($ million)
  • POC Blood and Electrolyte Professional Testing
    • Table 4-6: Global POC Blood and Electrolyte Professional Testing Market Analysis, 2024-2029 ($ million)
  • Competitive Analysis
    • Table 4-7: Global POC Blood and Electrolyte Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Others]
    • Figure 4-6: Global POC Blood and Electrolyte Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Others]
    • Figure 4-7: Global POC Blood and Electrolyte Testing Market Manufacturer Share, 2024 (%) [Abbott, Beckman Coulter, Radiometer, Siemens Healthineers, Sysmex, Others]

Chapter 5: POC Rapid Coagulation

• Products
  • Table 5-1: Selected POC Coagulation Test Innovations
  • Platelet Testing
    • Table 5-2: Selected Platelet Activity Test Innovations
• Market Size and Growth
  • Table 5-3: Global Rapid Coagulation Testing Market Analysis, 2024-2029 ($ million)
  • Figure 5-1: Global Rapid Coagulation Testing Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 5-2: POC Rapid Coagulation Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Rapid Coagulation Self-Testing
    • Table 5-4: POC Rapid Coagulation Self-Testing Market Analysis, 2024-2029 ($ million)
  • POC Rapid Coagulation Professional Testing
    • Table 5-5: POC Rapid Coagulation Professional Testing Market Analysis, 2024-2029 ($ million)
    • Figure 5-3: POC Rapid Coagulation Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
• Competitive Analysis
  • Table 5-6: Global POC Rapid Coagulation Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million)
  • Figure 5-4: Global POC Rapid Coagulation Testing Market, Revenues of Leading Suppliers, 2024 ($ million)
  • Figure 5-5: Global POC Rapid Coagulation Testing Market, Market Share of Leading Suppliers, 2024 (%)

Chapter 6: POC Rapid Cardiac Markers

• Products
• Market Size and Growth
  • Table 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2024-2029 ($ million)
  • Figure 6-1: Total Rapid Cardiac Markers Tests Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 6-2: POC Rapid Cardiac Markers Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
• Competitive Analysis
  • Table 6-2: Global POC Cardiac Markers Test Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
  • Figure 6-3: Global POC Cardiac Markers Test Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]
  • Figure 6-4: Global POC Cardiac Markers Test Manufacturers, Market Share of Leading Suppliers, 2024 (%) [Abbott, QuidelOrtho, Roche, Siemens Healthineers, Others]

Chapter 7: POC Substance Abuse

• Overview
• Products
  • Urine
  • Oral
  • Blood
  • Hair
• Market Size and Growth
  • Table 7-1: Global POC Drugs of Abuse Testing (critical care, employment, and criminal) Market Analysis, 2024-2029 ($ million)
  • Figure 7-1: Global POC Drugs of Abuse Testing (critical care, employment, and criminal) Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 7-2: POC Substance Abuse Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Drugs of Abuse Self-Testing
    • Table 7-2: Global POC Drugs of Abuse Self Testing Market, 2024-2029 ($ million)
  • POC Drugs of Abuse Professional Testing
    • Table 7-3: Global POC Drugs of Abuse Professional Testing Market Analysis, 2024-2029 ($ million)
    • Figure 7-3: Global POC Drugs of Abuse Market, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
• Competitive Analysis
  • Table 7-4: Global POC Drugs of Abuse Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
  • Figure 7-4: Global POC Drugs of Abuse Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]
  • Figure 7-5: Global POC Drug of Abuse Testing Manufacturer Market Share, by Leading Suppliers, 2024 (%) [Abbott, Roche, Siemens Healthineers, Thermo Fisher, Others]

Chapter 8: POC Pregnancy and Fertility Testing

• Products
  • Table 8-1: Selected Pregnancy and Fertility CLIA Waivers (Manufacturer and Instrument / Assay), Manufacturer's Instrument / Device / Assay
• Market Size and Growth
  • Table 8-2: Global POC Pregnancy and Fertility Testing Market Analysis, 2024-2029 ($ million)
  • Figure 8-1: Global POC Pregnancy and Fertility Testing Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 8-2: POC Pregnancy and Fertility Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Pregnancy and Fertility Self-Testing
    • Table 8-3: POC Pregnancy and Fertility Self-Testing Market Analysis, 2024-2029 ($ million)
  • POC Pregnancy and Fertility Professional Testing
    • Table 8-4: POC Pregnancy and Fertility Professional Testing Market Analysis, 2024-2029 ($ million)
    • Figure 8-3: POC Pregnancy and Fertility Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
• Competitive Analysis
  • Table 8-5: Global POC Pregnancy and Fertility Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [bioMerieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
  • Figure 8-4: Global POC Pregnancy and Fertility Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [bioMerieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]
  • Figure 8-5: Global POC Pregnancy and Fertility Testing Manufacturer Share, by Leading Suppliers, 2024 (%) [bioMerieux, Church & Dwight, Meridian, QuidelOrtho, SPD, Others]

Chapter 9: POC Colon Cancer Screening/Fecal Occult Blood Testing

• Products
  • Table 9-1: Selected POC Colon Cancer Tests
• Market Size and Growth
  • Table 9-2: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2024-2029 ($ million)
  • Figure 9-1: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 9-2: POC Colon Cancer Screening/Fecal Occult Blood Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Colon Cancer Screening/Fecal Occult Blood Self-Testing
    • Table 9-3: POC Colon Cancer Screening/Fecal Occult Blood Self-Testing Market Analysis, 2024-2029 ($ million)
  • POC Colon Cancer Screening/Fecal Occult Blood Professional Testing
    • Table 9-4: POC Colon Cancer Screening/Fecal Occult Blood Professional Testing Market Analysis, 2024-2029 ($ million)
    • Figure 9-3: POC Colon Cancer Screening/Fecal Occult Blood Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
• Competitive Analysis
  • Table 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million)
  • Figure 9-4: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Beckman Coulter, Exact Sciences, Others]
  • Figure 9-5: Global POC Colon Cancer Screening/Fecal Occult Blood Testing Manufacturers Share, by Leading Suppliers, 2024 (%) [Beckman Coulter, Exact Sciences, Others]

Chapter 10: POC Infectious Disease Testing

• Products
  • HIV and Hepatitis
  • Respiratory
  • STD/STI
  • Tropical Diseases
  • Lyme Disease
  • TB
  • Zika
  • Anthrax
  • Other Bacteria and Viruses
  • Hospital-Acquired Infections and Sepsis
  • Sepsis
  • C. Diff
    • Table 10-1: Selected Innovations in POC Infectious Disease Diagnostics
  • COVID-19
  • Antigen
    • Table 10-2: Selected Antigen POC and Home Immunoassay Tests for SARS-CoV-2
  • Molecular
    • Table 10-3: Selected Molecular POC Home Tests for SARS-CoV-2
• Market Size and Growth
  • Table 10-4: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2024-2029 ($ million)
  • Figure 10-1: Global POC Infectious Disease (including COVID-19) Testing Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 10-2: POC Infectious Disease (including COVID-19) Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Infectious Disease Self-Testing
    • Table 10-5: POC Infectious Disease Self-Testing (including COVID-19) Market Analysis, 2024-2029 ($ million)
  • POC Infectious Disease Professional Testing
    • Table 10-6: POC Infectious Disease (including COVID-19) Professional Testing Market Analysis, 2024-2029 ($ million)
    • Figure 10-3: POC Infectious Disease Testing (including COVID-19) Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
  • POC Infectious Disease Testing by Disease Type
    • Table 10-7: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market, by Disease Type, 2024 ($ million) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
    • Figure 10-4: Global POC Infectious Disease Revenues, by Disease Type, 2024 ($ million) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
    • Figure 10-5: Global POC Infectious Disease, Percent of Infectious Disease Market by Disease Type, 2024 (%) [C. Diff, COVID-19, E. coli, H. pylori, Hepatitis, HIV, Home Test/OTC, Influenza, Malaria, STD, Others]
• Competitive Analysis
  • Table 10-8: Global POC Infectious Disease (including COVID-19) Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
  • Figure 10-6: Global POC Infectious Disease (including COVID-19) Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]
  • Figure 10-7: Global POC Infectious Disease (including COVID-19) Testing Manufacturers, Market Share of Leading Suppliers, 2024 (%) [Abbott, Becton Dickinson, OraSure, QuidelOrtho, Roche, Siemens Healthineers, Others]

Chapter 11: POC Lipid Testing

• Products
• Market Size and Growth
  • Table 11-1: Global POC Lipid Testing Market Analysis, 2024-2029 ($ million)
  • Figure 11-1: Global POC Lipid Testing Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 11-2: POC Lipid Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Lipid Self-Testing
    • Table 11-2: POC Lipid Self-Testing Market Analysis, 2024-2029 ($ million)
  • POC Lipid Professional Testing
    • Table 11-3: POC Lipid Professional Testing Market Analysis, 2024-2029 ($ million)
    • Figure 11-3: POC Lipid Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
• Competitive Analysis
  • Table 11-4: Global POC Lipid Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abaxis, Abbott, Roche, Others]
  • Figure 11-4: Global POC Lipid Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Abaxis, Abbott, Roche, Others]
  • Figure 11-5: Global POC Lipid Testing Manufacturers Share, 2024 (%) [Abaxis, Abbott, Roche, Others]

Chapter 12: POC Cancer Tumor Marker Testing

• Products
  • Table 12-1: Selected Companies Developing and/or Marketing POC Tests for Oncology Indications
• Market Size and Growth
  • Table 12-2: Global POC Cancer Testing Market Analysis, 2024-2029 ($ million)
  • Figure 12-1: Global POC Cancer Testing Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 12-2: POC Cancer Tumor Marker Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
• Competitive Analysis
  • Table 12-3: Global POC Cancer Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Beckman Coulter, bioMerieux, QuidelOrtho, Others]
  • Figure 12-3: Global POC Cancer Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Beckman Coulter, bioMerieux, QuidelOrtho, Others]
  • Figure 12-4: Global POC Cancer Testing Manufacturers Share, by Leading Suppliers, 2024 (%) [Beckman Coulter, bioMerieux, QuidelOrtho, Others]

Chapter 13: POC Urine Testing

• Products
• Market Size and Growth
  • Table 13-1: Global POC Urine Testing Market Analysis, 2024-2029 ($ million)
  • Figure 13-1: Global POC Urine Testing Market Analysis, 2024-2029 ($ million)
  • Regional Analysis
    • Figure 13-2: POC Urine Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]
  • POC Urine Self-Testing
    • Table 13-2: POC Urine Self-Testing Market Analysis, 2024-2029 ($ million)
  • POC Urine Test Professional Testing
    • Table 13-3: POC Urine Professional Testing Market Analysis, 2024-2029 ($ million)
    • Figure 13-3: POC Urine Market Analysis, Self-Testing vs. Professional Testing, 2024-2029 ($ million)
• Competitive Analysis
  • Table 13-4: Global POC Urine Testing Market, Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]
  • Figure 13-4: Global POC Urine Testing Market, Revenues of Leading Suppliers, 2024 ($ million) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]
  • Figure 13-5: Global POC Urine Strip Testing Manufacturers Share, by Leading Suppliers, 2024 (%) [Eiken Chemical, Roche, Siemens Healthineers, Sysmex, Others]

Chapter 14: Miscellaneous POC Testing

• Microbiology
• TSH
• Allergy
• Autoimmune
• Others
• Market Size and Growth
  • Table 14-1: Global Miscellaneous POC Testing Market Analysis, 2024-2029 ($ million)
  • Figure 14-1: Global Miscellaneous POC Testing Market Analysis, 2024-2029 ($ million)
  • Table 14-2: Global POC Miscellaneous Sales, by Test Category, 2024-2029 ($ million) [Allergy, Autoimmune, Microbiology, TSH, Others]
  • Figure 14-2: Global POC Miscellaneous Sales, by Test Category, 2024-2029 ($ million) [Allergy, Autoimmune, Microbiology, TSH, Others]
  • Figure 14-3: Global POC Miscellaneous Market Share, by Test Category, 2024 (%) [Allergy, Autoimmune, Microbiology, TSH, Others]
  • Figure 14-4: Global POC Miscellaneous Market Share, by Test Category, 2029 (%) [Allergy, Autoimmune, Microbiology, TSH, Others]
  • POC Miscellaneous Test Sales by Setting
    • Table 14-3: POC Miscellaneous Test Sales, by Setting, 2024-2029 ($ million) [Self-Testing vs. Professional Testing]
    • Figure 14-5: POC Miscellaneous Test Sales, by Setting, 2024-2029 ($ million) [Self-Testing vs. Professional Testing]
  • Regional Analysis
    • Figure 14-6: POC Miscellaneous Testing Regional Market Share Analysis, 2024 (%) [Europe, Japan, United States, Rest of World]

Chapter 15: Issues and Trends

• Overview
• Wearables
  • Table 15-1: Selected Wearable Devices
• Mobile Healthcare Technologies
• Telehealth
• Telehealth eMed to Implement Home Test-to-Treat Program
• Patient-centered Healthcare
• Breath Test Advances
  • Table 15-2: Selected Disease Markers in Exhaled Breath
• Regulatory Hurdles
• Reimbursement Challenges
• PAMA
• Competition
• POC and Molecular Diagnostics
  • Table 15-3: Selected Market Available Molecular POC Diagnostic Platforms
• POC Biosensors and Microfluidics
  • Table 15-4: Selected FDA-Approved Microfluidic-based POC Tests 2024
  • Table 15-5: Selected Biochip and Biosensor Players, 2024
• China as a POC Market
• Emerging POC Technologies
• POC Connectivity
• COVID-19 Impact
• Multiplexed POC Testing
  • Figure 15-1: Multiplexed POC Testing Schematic
• The Emergence of Non-invasive Technologies
  • Saliva and Swab
  • Optical Techniques
  • Near-infrared Scanning
  • Volatolomics
• POC and Antibiotic Resistance Concern
• Artificial Intelligence in POC
• POC Future in Infectious Disease Diagnostics
• Supply Chain Delays
• Stand-Alone Emergency Department /Urgent Care Centers Combine with POC Team in New Mexico
• Digital Diagnostics
• Microfluidics and POC
• POC Testing in Genomics and Personalized Medicine
• Lab-Developed Tests
• CRISPR-Cas Technology and POC
• Staffing Shortages

Chapter 16: Total Global POC Testing Market and Competitor Analysis

• Market Overview
  • Table 16-1: Global POC Test Market, 2024-2029 ($ million)
  • Figure 16-1: Global POC Test Market, 2024-2029 ($ million)
• Market Analysis by Product Categories
  • Table 16-2: Global POC Testing Market Analysis, by Product Category, 2024 ($ million) [Professional Testing, Self-Testing]
  • Figure 16-2: Global POC Testing Market Analysis, by Product Category, 2024 ($ million) [Professional Testing, Self-Testing]
  • Figure 16-3: Global POC Testing Market Share Analysis, by Product Category, 2024 (%) [Professional Testing, Self-Testing]
• Market Analysis by Subcategory
  • POC Self-Testing
    • Table 16-3: Global POC Self-Testing Market Analysis, by Product Category, 2024 ($ million) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
    • Figure 16-4: Global POC Self-Testing Market Analysis, by Product Category, 2024 ($ million) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
    • Figure 16-5: Global POC Self-Testing Market Share Analysis, by Product Category, 2024 (%) [Blood & Electrolytes, Coagulation, Drugs of Abuse, Fecal Occult Blood, Glucose (includes CGM), Infectious Disease, Lipid, Pregnancy & Fertility, Urine, Miscellaneous]
  • POC Professional Testing
    • Table 16-4: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 ($ million) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
    • Figure 16-6: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 ($ million) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
    • Figure 16-7: Global POC Professional Testing Market Analysis, by Product Subcategory, 2024 (%) [Blood & Electrolytes, Cancer Tumor Markers, Cardiac Markers, DOA, Fecal Occult Blood, Glucose includes HbA1c, Infectious Disease, Lipid, Pregnancy & Fertility, Product Type, Rapid Coagulation, Urine, Miscellaneous]
• Market Analysis by Country
  • Table 16-5: Global POC Testing Analysis, by Region/Country, 2024 ($ million) [Europe, Japan, United States, Rest of World]
  • Figure 16-8: Global POC Testing Analysis, by Region/Country, 2024 ($ million) [Europe, Japan, United States, Rest of World]
  • Figure 16-9: Global POC Testing Market Analysis, Share by Region/Country, 2024 (%) [Europe, Japan, United States, Rest of World]
  • United States
    • Table 16-6: United States POC Testing Market Analysis, 2024-2029 ($ million)
  • Europe
    • Table 16-7: Europe POC Testing Market Analysis, 2024-2029 ($ million)
  • Germany
  • France
  • UK
  • Switzerland and Sweden
  • Russia and Other Europe
    • Figure 16-10: Europe POC Testing Participation, Share of European Market by Country, 2024 (%) [France, Germany, Italy, Spain, Switzerland/Norway, United Kingdom, Others]
  • Japan
    • Table 16-8: Japan POC Testing Market Analysis, 2024-2029 ($ million)
  • Rest of World
  • Latin America
  • China
  • India
  • South Korea
  • Other Rest of World Countries
    • Table 16-9: Global POC Testing Market Analysis, by Rest of World Region/Country, 2024 ($ million) [Australia, Canada, China, India, Latin America, the Middle East, South Korea and other Asian countries, Other]
    • Figure 16-11: Global POC Testing Market Analysis, Share of Rest of World by Region/Country, 2024 (%) [Australia, China, India, Latin America, South Korea, Other]
• Competitive Analysis
  • Table 16-10: Global Top 10 POC Testing Market Revenues and Market Share of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
  • Figure 16-12: Global Top 10 POC Testing Market Revenues of Leading Suppliers, 2024 ($ million) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]
  • Figure 16-13: Global POC Testing Market Share by Leading Suppliers, 2024 (%) [Abbott, Ascensia Diabetes Care, Danaher, Dexcom, Exact Sciences, LifeScan, Medtronic, QuidelOrtho, Roche, Siemens Healthineers, Others]

Chapter 17: Corporate Profiles

• Overview
• 1 Step Detect Associates, LLC
  • Table 17-1: 1-Step Detect Associates Corporate Summary
  • Company Overview
  • Products
• Abbott Laboratories
  • Table 17-2: Abbott Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-3: Abbott Revenues, 2020-2024 ($ million)
• Abingdon Health Ltd.
  • Table 17-4: Abingdon Health Corporate Summary
• Company Overview
  • Products
• Access Bio, Inc.
  • Table 17-5: Access Bio Corporate Summary
  • Company Overview
  • Products
• AccuBioTech Co, Ltd.
  • Table 17-6: AccuBioTech Corporate Summary
  • Company Overview
  • Products
• ACON Laboratories, Inc
  • Table 17-7: ACON Laboratories Corporate Summary
  • Company Overview
  • Products
• Aerscher Diagnostics, LLC
  • Table 17-8: Aerscher Diagnostics Corporate Summary
  • Company Overview
  • Products
• Alfa Scientific Designs, Inc
  • Table 17-9: Alfa Scientific Corporate Summary
  • Company Overview
  • Products
• ARKRAY, Inc.
  • Table 17-10: ARKRAY Corporate Summary
  • Company Overview
  • Products
• Artron Laboratories, Inc
  • Table 17-11: Artron Laboratories Corporate Summary
  • Company Overview
  • Products
• Ascensia Diabetes Care Holdings AG
  • Table 17-12: Ascensia Diabetes Care Corporate Summary
  • Company Overview
  • Products
• Autobio Diagnostics Co., Ltd
  • Table 17-13: Autobio Diagnostics Corporate Summary
  • Company Overview
  • Products
• Beckman Coulter, Inc
  • Table 17-14: Beckman Coulter Corporate Summary
  • Company Overview
  • Products
• Becton Dickinson (BD)
  • Table 17-15: BD Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-16: BD Corporation Revenue, 2023-2024 ($ million)
• Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
  • Table 17-17: Beijing Wantai Biological Pharmacy Enterprise Corporate Summary
  • Company Overview
  • Products
• Bhat Bio-Tech India Private Ltd. (BBI)
  • Table 17-18: Bhat Bio-Tech India Private Corporate Summary
  • Company Overview
  • Products
• binx health
  • Table 17-19: binx health Corporate Summary
  • Company Overview
  • Products
• bioLytical Laboratories
  • Table 17-20: bioLytical Laboratories Corporate Summary
  • Company Overview
  • Products
• BioMedomics, Inc
  • Table 17-21: BioMedomics Corporate Summary
  • Company Overview
  • Products
• Biomeme, Inc
  • Table 17-22: Biomeme Corporate Summary
  • Company Overview
  • Products
• Biomerica, Inc.
  • Table 17-23: Biomerica Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-24: Biomerica Corporation Revenue, 2020-2024 ($ million)
• bioMerieux SA
  • Table 17-25: bioMerieux SA Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-26: bioMerieux Revenues, 2023-2024 (Euro- million)
• Bio-Rad Laboratories Inc.
  • Table 17-27: Bio-Rad Labs Corporate Summary
  • Company Overview
  • Products
  • Company Financials
    • Table 17-28: Bio-Rad Corporation Revenue, 2023-2024 ($ million)
• Biosynex SA
  • Table 17-29: Biosynex SA Corporate Summary
  • Company Overview
  • Products
• Biotron Diagnostics, Inc.
  • Table 17-30: Biotron Diagnostics Corporate Summary
  • Company Overview
  • Products
• Boditech Med Inc.
  • Table 17-31: Boditech Med Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-32: Boditech Med Revenues, 2023-2024 (KRW billion)
• Boson Biotech Co. Ltd
  • Table 17-33: Boson Biotech Corporate Summary
  • Company Overview
  • Products
• BTNX Inc.
  • Table 17-34: BTNX Corporate Summary
  • Company Overview
  • Products
• Cepheid, Inc.
  • Table 17-35: Cephid Corporate Summary
  • Company Overview
  • Products
• Chembio Diagnostics Systems, Inc. (Biosynex)
  • Table 17-36: Chembio Diagnostic Corporate Summary
  • Company Overview
  • Products
• Church & Dwight Co. Inc
  • Table 17-37: Church & Dwight Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-38: Church and Dwight Revenues, 2023-2024 ($ million)
• Clarity Diagnostics, LLC
  • Table 17-39: Clarity Diagnostics Corporate Summary
  • Company Overview
  • Products
• Confirm Biosciences
  • Table 17-40: Confirm Biosciences Corporate Summary
  • Company Overview
  • Products
• CTK Biotech, Inc.
  • Table 17-41: CTK Biotech Corporate Summary
  • Company Overview
  • Products
• Cue Health
  • Table 17-42: Cue Health Corporate Summary
  • Company Overview
  • Products
• Danaher Corporation
  • Table 17-43: Danaher Corporation Summary
  • Company Overview
  • Products
• Dexcom, Inc
  • Table 17-44: Dexcom Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-45: Dexcom Revenues, 2023-2024 ($ million)
• DIALAB GmbH
  • Table 17-46: DIALAB Corporate Summary
  • Company Overview
  • Products
• DiaSys Diagnostic Systems GmbH (Mindray)
  • Table 17-47: DiaSys Diagnostic Systems Corporate Summary
  • Company Overview
  • Products
• Diazyme Laboratories, Inc.
  • Table 17-48: Diazyme Laboratories Corporate Summary
  • Company Overview
  • Products
• DNA Electronics Ltd. (DNAe)
  • Table 17-49: DNA Electronics Corporate Summary
  • Company Overview
  • Products
• Dr. Fooke-Achterrath Laboratorien GmbH
  • Table 17-50: Dr. Fooke-Achterrath Laboratorien Corporate Summary
  • Company Overview
  • Products
• DxGen Corp.
  • Table 17-51: DxGen Corporate Summary
  • Company Overview
  • Products
• Eiken Chemical Co Ltd.
  • Table 17-52: Eiken Chemical Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-53: Eiken Chemical Revenues, 2023-2024 (million yen)
• EKF Diagnostics Holdings plc
  • Table 17-54: EKF Diagnostics Corporate Summary
  • Company Overview
  • Products
• ELITechGroup S.A.S.
  • Table 17-55: ELITechGroup Corporate Summary
  • Company Overview
  • Products
• Eurobio Scientific
  • Table 17-56: Eurobio Scientific Corporate Summary
  • Company Overview
  • Products
• Everlywell
  • Table 17-57: Everlywell Corporate Summary
  • Company Overview
  • Products
• Exact Sciences
  • Table 17-58: Exact Sciences Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-59: Exact Sciences Revenues, 2023-2024 ($ million)
• EY Laboratories
  • Table 17-60: EY Laboratories Corporate Summary
  • Company Overview
  • Products
• GenBio
  • Table 17-61: GenBio Corporate Summary
  • Company Overview
  • Products
• genedrive plc
  • Table 17-62: genedrive Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-63: genedrive Revenue, 2023-2024 (Pound- million)
• GeTein Biotech Inc.
  • Table 17-64: GeTein Corporate Summary
  • Company Overview
  • Products
• Helena Laboratories
  • Table 17-65: Helena Laboratories Corporate Summary
  • Company Overview
  • Products
• Hemosure, Inc. (W.H.P.M)
  • Table 17-66: Hemosure Corporate Summary
  • Company Overview
  • Products
• HORIBA, Ltd.
  • Table 17-67: HORIBA Corporate Summary
  • Company Overview
  • Products
• Immune IQ
  • Table 17-68: Immune IQ Corporate Summary
  • Company Overview
  • Products
• Immunostics, Inc
  • Table 17-69: Immunostics Corporate Summary
  • Company Overview
  • Products
• JAL Innovation PTE LTD
  • Table 17-70: JAL Innovation Corporate Summary
  • Company Overview
  • Products
• Jant Pharmacal Corporation
  • Table 17-71: Jant Pharmacal Corporate Summary
  • Company Overview
  • Products
• J. Mitra & Co Pvt. Ltd
  • Table 17-72: J Mitra Corporate Summary
  • Company Overview
  • Products
• Kypha
  • Table 17-73: Kypha Corporate Summary
  • Company Overview
  • Products
• LamdaGen Corporation
  • Table 17-74: LamdaGen Corporate Summary
  • Company Overview
  • Products
• LifeScan, Inc
  • Table 17-75: LifeScan Corporate Summary
  • Company Overview
  • Products
• LifeSign, LLC
  • Table 17-76: LifeSign Corporate Summary
  • Company Overview
  • Products
• LightDeck Diagnostics
  • Table 17-77: LightDeck Diagnostics Corporate Summary
  • Company Overview
  • Products
• LumiraDx UK Limited
  • Table 17-78: LumiraDx Corporate Summary
  • Company Overview
  • Products
• Macherey-Nagel GmbH & Co. KG
  • Table 17-79: Macherey-Nagel Corporate Summary
  • Company Overview
  • Products
• Medix Biochemica
  • Table 17-80: Medix Biochemica Corporate Summary
  • Company Overview
  • Products
• MedMira, Inc
  • Table 17-81: MedMira Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-82: MedMira Revenues, 2023-2024 ($ thousands)
• Medtronic, Inc.
  • Table 17-83: Medtronic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-84: Medtronic Revenues, 2023-2024 ($ billion)
• A. Menarini Diagnostics srl.
  • Table 17-85: Menarini Diagnostics Corporate Summary
  • Company Overview
  • Products
• Meridian Bioscience, Inc
  • Table 17-86: Meridian Bioscience Corporate Summary
  • Company Overview
  • Products
• MiCo BioMed
  • Table 17-87: MiCo BioMed Summary
  • Company Overview
  • Products
• Nano-Ditech Corporation
  • Table 17-88: Nano-Ditech Corporate Summary
  • Company Overview
  • Products
• Nexus Dx Inc
  • Table 17-89: Nexus Dx Corporate Summary
  • Company Overview
  • Products
• NG Biotech
  • Table 17-90: NG Biotech Corporate Summary
  • Company Overview
  • Products
• Noble Medical, Inc
  • Table 17-91: Noble Medical Corporate Summary
  • Company Overview
  • Products
• Nova Biomedical Corp.
  • Table 17-92: Nova Biomedical Corporate Summary
  • Company Overview
  • Products
• Oasis Diagnostics Corporation
  • Table 17-93: Oasis Diagnostics Corporate Summary
  • Company Overview
  • Products
• Operon S.A.
  • Table 17-94: Operon Corporate Summary
  • Company Overview
  • Products
• OPKO Health, Inc
  • Table 17-95: OPKO Health Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-96: OPKO Health Revenues, 2023-2024 ($ million)
• OraSure Technologies, Inc.
  • Table 17-97: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-98: OraSure Revenues, 2023-2024 ($ million)
• PixCell Medical Technologies
  • Table 17-99: PixCell Corporate Summary
  • Company Overview
  • Products
• Polymedco, Inc
  • Table 17-100: Polymedco Corporate Summary
  • Company Overview
  • Products
• PTS Diagnostics
  • Table 17-101: PTS Corporate Summary
  • Company Overview
  • Products
• Preventis GmbH
  • Table 17-102: Preventis Corporate Summary
  • Company Overview
  • Products
• Princeton Biomeditech Corporation
  • Table 17-103: Princeton Biomeditech Corporate Summary
  • Company Overview
  • Products
• QuantuMDx Group Limited
  • Table 17-104: QuantuMDx Group Corporate Summary
  • Company Overview
  • Products
• QuidelOrtho Corporation
  • Table 17-105: QuidelOrtho Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-106: QuidelOrtho Revenues, 2023-2024 ($ million)
• Precision Biosensor
  • Table 17-107: Precision Biosensor Corporate Summary
  • Company Overview
  • Products
• Radiometer Medical A/S
  • Table 17-108: Radiometer Medical Corporate Summary
  • Company Overview
  • Products
• Randox Laboratories Limited
  • Table 17-109: Randox Labs Corporate Summary
  • Company Overview
  • Products
• Response Biomedical Corp
  • Table 17-110: Response Biomedical Corporate Summary
  • Company Overview
  • Products
• Reszon Diagnostics International Sdn. Bhd.
  • Table 17-111: Reszon Diagnostics Corporate Summary
  • Company Overview
  • Products
• Roche Diagnostic Corporation
  • Table 17-112: Roche Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Table 17-113: Roche POC Marketed Products
  • Performance Review
    • Table 17-114: Roche Diagnostics, 2023-2024 (CHF millions)
• Savyon Diagnostics
  • Table 17-115: Savyon Diagnostics Corporate Summary
  • Company Overview
  • Products
• Sekisui Diagnostics LLC
  • Table 17-116: Sekisui Diagnostics Corporate Summary
  • Company Overview
  • Products
• Siemens Healthineers GmbH
  • Table 17-117: Siemens Healthineers Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-118: Siemens Healthineers, 2023-2024 (Euro- millions)
• Sysmex Corporation
  • Table 17-119: Sysmex Corporate Summary
  • Company Overview
  • Products
  • Performance Review
    • Table 17-120: Sysmex, 2023-2024 (billion yen)
• TECHLAB, Inc.
  • Table 17-121: TECHLAB Corporate Summary
  • Company Overview
  • Products
• Trinity Biotech PLC
  • Table 17-122: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
• Trividia Health
  • Table 17-123: Trividia Health Corporate Summary
  • Company Overview
  • Products
• Tulip Diagnostics Ltd (Tulip Group)
  • Table 17-124: Tulip Diagnostics Corporate Summary
  • Company Overview
  • Product
• VedaLab
  • Table 17-125: VedaLab Corporate Summary
  • Company Overview
  • Products
• Werfen
  • Table 17-126: Werfen Corporate Summary
  • Company Overview
  • Products